# Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension

> **NCT04790942** · PHASE4 · UNKNOWN · sponsor: **Jun Tao** · enrollment: 30 (estimated)

## Conditions studied

- Hypertension
- Endothelial Dysfunction
- Blood Pressure

## Interventions

- **DRUG:** berberine hydrochloride
- **BEHAVIORAL:** lifestyle intervention group

## Key facts

- **NCT ID:** NCT04790942
- **Lead sponsor:** Jun Tao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-22
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-05-22
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790942, "Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04790942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*